{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T02:40:03Z","timestamp":1750646403444,"version":"3.41.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T00:00:00Z","timestamp":1500249600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14\/01637","INT16\/00172","CD13\/00032"],"award-info":[{"award-number":["PI14\/01637","INT16\/00172","CD13\/00032"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. of Cardiovasc. Trans. Res."],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s12265-017-9761-1","type":"journal-article","created":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T14:31:18Z","timestamp":1500301878000},"page":"460-469","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Early Anti-inflammatory and Pro-angiogenic Myocardial Effects of Intravenous Serelaxin Infusion for 72\u00a0H in an Experimental Rat Model of Acute Myocardial Infarction"],"prefix":"10.1007","volume":"10","author":[{"given":"Jesus","family":"Sanchez-Mas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Lax","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari C.","family":"Asensio-Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Lencina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria J","family":"Fernandez-del Palacio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Soriano-Filiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf A.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domingo A.","family":"Pascual-Figal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,17]]},"reference":[{"key":"9761_CR1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1152\/physrev.00001.2012","volume":"93","author":"RA Bathgate","year":"2013","unstructured":"Bathgate, R. A., Halls, M. L., van der Westhuizen, E. T., Callander, G. E., Kocan, M., & Summers, R. J. (2013). Relaxin family peptides and their receptors. Physiological Reviews, 93, 405\u2013480.","journal-title":"Physiological Reviews"},{"key":"9761_CR2","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/1074248415617851","volume":"21","author":"JMV Raleigh","year":"2016","unstructured":"Raleigh, J. M. V., Toldo, S., Das, A., Abbate, A., & Salloum, F. N. (2016). Relaxin\u2019 the heart: a novel therapeutic modality. Journal of Cardiovascular Pharmacology and Therapeutics, 21, 353\u2013362.","journal-title":"Journal of Cardiovascular Pharmacology and Therapeutics"},{"key":"9761_CR3","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(09)60622-X","volume":"373","author":"JR Teerlink","year":"2009","unstructured":"Teerlink, J. R., Metra, M., Felker, G. M., Ponikowski, P., Voors, A. A., Weatherley, B. D., Marmor, A., Katz, A., Grzybowski, J., Unemori, E., Teichman, S. L., & Cotter, G. (2009). Relaxin for the treatment of patients with acute heart failure (pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study. Lancet, 373, 1429\u20131439.","journal-title":"Lancet"},{"key":"9761_CR4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(12)61855-8","volume":"381","author":"JR Teerlink","year":"2013","unstructured":"Teerlink, J. R., Cotter, G., Davison, B. A., Felker, G. M., Filippatos, G., Greenberg, B. H., Ponikowski, P., Unemori, E., Voors, A. A., Adams Jr., K. F., Dorobantu, A. M. I., Grinfeld, L. R., Jondeau, G., Marmor, A., Masip, J., Pang, P. S., Werdan, K., Teichman, S. L., Trapani, A., Bush, C. A., Saini, R., Schumacher, C., Severin, T. M., & Metra, M. (2013). RELAXin in Acute Heart Failure (RELAX-AHF) investigators. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet, 381, 29\u201339.","journal-title":"Lancet"},{"key":"9761_CR5","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/ejhf.830","volume":"19","author":"JR Teerlink","year":"2017","unstructured":"Teerlink, J. R., Voors, A. A., Ponikowski, P., Pang, P. S., Greenberg, B. H., Filippatos, G., Felker, G. M., Davison, B. A., Cotter, G., Gimpelewicz, C., Boer-Martins, L., Wernsing, M., Hua, T. A., Severin, T., & Metra, M. (2017). Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study. European Journal of Heart Failure, 19, 800\u2013809.","journal-title":"European Journal of Heart Failure"},{"key":"9761_CR6","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1210\/endo.138.11.5520","volume":"138","author":"E Masini","year":"1997","unstructured":"Masini, E., Bani, D., Bello, M. G., Bigazzi, M., Mannaioni, P. F., & Sacchi, T. B. (1997). Relaxin counteracts myocardial damage induced by ischemia-reperfusion in isolated guinea pig hearts: evidence for an involvement of nitric oxide. Endocrinology, 138, 4713\u20134720.","journal-title":"Endocrinology"},{"key":"9761_CR7","first-page":"1367","volume":"152","author":"D Bani","year":"1998","unstructured":"Bani, D., Masini, E., Bello, M. G., Bigazzi, M., & Sacchi, T. B. (1998). Relaxin protects against myocardial injury caused by ischemia and reperfusion in rat heart. The American Journal of Pathology, 152, 1367\u20131376.","journal-title":"The American Journal of Pathology"},{"key":"9761_CR8","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1096\/fj.04-3664fje","volume":"19","author":"AM Perna","year":"2005","unstructured":"Perna, A. M., Masini, E., Nistri, S., Briganti, V., Chiappini, L., Stefano, P., Bigazzi, M., Pieroni, C., Bani Sacchi, T., & Bani, D. (2005). Novel drug development opportunity for relaxin in acute myocardial infarction: evidences from a swine model. The FASEB Journal, 19, 1525\u20131527.","journal-title":"The FASEB Journal"},{"key":"9761_CR9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.phrs.2007.11.001","volume":"57","author":"S Nistri","year":"2008","unstructured":"Nistri, S., Cinci, L., Perna, A.-M., Masini, E., Mastroianni, R., & Bani, D. (2008). Relaxin induces mast cell inhibition and reduces ventricular arrhythmias in a swine model of acute myocardial infarction. Pharmacological Research, 57, 43\u201348.","journal-title":"Pharmacological Research"},{"key":"9761_CR10","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1111\/j.1582-4934.2008.00503.x","volume":"13","author":"M Bonacchi","year":"2009","unstructured":"Bonacchi, M., Nistri, S., Nanni, C., Gelsomino, S., Pini, A., Cinci, L., Maiani, M., Zecchi-Orlandini, S., Lorusso, R., Fanti, S., Silvertown, J., & Bani, D. (2009). Functional and histopathological improvement of the post-infarcted rat heart upon myoblast cell grafting and relaxin therapy. Journal of Cellular and Molecular Medicine, 13, 3437\u20133448.","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"9761_CR11","first-page":"488","volume":"39","author":"G Lascio Di","year":"2012","unstructured":"Di Lascio, G., Harmelin, G., Targetti, M., Nanni, C., Bianchi, G., Gasbarri, T., Gelsomino, S., Bani, D., Orlandini, S. Z., & Bonacchi, M. (2012). Cellular retrograde cardiomyoplasty and relaxin therapy for postischemic myocardial repair in a rat model. Texas Heart Institute Journal, 39, 488\u2013499.","journal-title":"Texas Heart Institute Journal"},{"key":"9761_CR12","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/labinvest.2010.198","volume":"91","author":"CS Samuel","year":"2011","unstructured":"Samuel, C. S., Cendrawan, S., Gao, X. M., Ming, Z., Zhao, C., Kiriazis, H., Xu, Q., Tregear, G. W., Bathgate, R. A., & Du, X. J. (2011). Relaxin remodels fibrotic healing following myocardial infarction. Laboratory Investigation, 91, 675\u2013690.","journal-title":"Laboratory Investigation"},{"key":"9761_CR13","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/jcmm.12120","volume":"17","author":"M Collino","year":"2013","unstructured":"Collino, M., Rogazzo, M., Pini, A., Benetti, E., Rosa, A. C., Chiazza, F., Fantozzi, R., Bani, D., & Masini, E. (2013). Acute treatment with relaxin protects the kidney against ischaemia\/reperfusion injury. Journal of Cellular and Molecular Medicine, 17, 1494\u20131505.","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"9761_CR14","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.healun.2009.09.012","volume":"29","author":"K Alexiou","year":"2010","unstructured":"Alexiou, K., Matschke, K., Westphal, A., Stangl, K., & Dschietzig, T. (2010). Relaxin is a candidate drug for lung preservation: relaxin-induced protection of rat lungs from ischemia-reperfusion injury. The Journal of Heart and Lung Transplantation, 29, 454\u2013460.","journal-title":"The Journal of Heart and Lung Transplantation"},{"key":"9761_CR15","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/sj.bjp.0706811","volume":"148","author":"E Masini","year":"2006","unstructured":"Masini, E., Cuzzocrea, S., Mazzon, E., Mui\u00e0, C., Vannacci, A., Fabrizi, F., & Bani, D. (2006). Protective effects of relaxin in ischemia\/reperfusion-induced intestinal injury due to splanchnic artery occlusion. British Journal of Pharmacology, 148, 1124\u20131132.","journal-title":"British Journal of Pharmacology"},{"key":"9761_CR16","first-page":"945","volume":"2013","author":"W Chen","year":"1833","unstructured":"Chen, W., & Frangogiannis, N. G. (1833). Fibroblasts in post-infarction inflammation and cardiac repair. Biochimica et Biophysica Acta, 2013, 945\u2013953.","journal-title":"Biochimica et Biophysica Acta"},{"key":"9761_CR17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/01.HYP.0000171930.00697.2f","volume":"46","author":"ED Lekgabe","year":"2005","unstructured":"Lekgabe, E. D., Kiriazis, H., Zhao, C., Xu, Q., Moore, X. L., Su, Y., Bathgate, R. A., Du, X. J., & Samuel, C. S. (2005). Relaxin reverses cardiac and renal fibrosis in spontaneously hypertensive rats. Hypertension, 46, 412\u2013418.","journal-title":"Hypertension"},{"key":"9761_CR18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mce.2007.09.008","volume":"280","author":"RA Bathgate","year":"2008","unstructured":"Bathgate, R. A., Lekgabe, E. D., McGuane, J. T., Su, Y., Pham, T., Ferraro, T., Layfield, S., Hannan, R. D., Thomas, W. G., Samuel, C. S., & Du, X. J. (2008). Adenovirus-mediated delivery of relaxin reverses cardiac fibrosis. Molecular and Cellular Endocrinology, 280, 30\u201338.","journal-title":"Molecular and Cellular Endocrinology"},{"key":"9761_CR19","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1210\/en.2012-1114","volume":"153","author":"HP Gu","year":"2012","unstructured":"Gu, H. P., Lin, S., Xu, M., Yu, H. Y., Du, X. J., Zhang, Y. Y., Yuan, G., & Gao, W. (2012). Up-regulating relaxin expression by G-quadruplex interactive ligand to achieve antifibrotic action. Endocrinology, 153, 3692\u20133700.","journal-title":"Endocrinology"},{"key":"9761_CR20","doi-asserted-by":"crossref","first-page":"41152","DOI":"10.1074\/jbc.M112.409284","volume":"287","author":"LJ Chan","year":"2012","unstructured":"Chan, L. J., Rosengren, K. J., Layfield, S. L., Bathgate, R. A., Separovic, F., Samuel, C. S., Hossain, M. A., & Wade, J. D. (2012). Identification of key residues essential for the structural fold and receptor selectivity within the A-chain of human gene-2 (H2) relaxin. The Journal of Biological Chemistry, 287, 41152\u201341164.","journal-title":"The Journal of Biological Chemistry"},{"key":"9761_CR21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1515\/cclm-2016-0370","volume":"54","author":"DA Pascual-Figal","year":"2016","unstructured":"Pascual-Figal, D. A., Lax, A., Perez-Martinez, M. T., Del Carmen, A.-L. M., Sanchez-Mas, J., & Network, G. R. E. A. T. (2016). Clinical relevance of sST2 in cardiac diseases. Clinical Chemistry and Laboratory Medicine, 54, 29\u201335.","journal-title":"Clinical Chemistry and Laboratory Medicine"},{"key":"9761_CR22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2015.06.025","volume":"763","author":"WC Meijers","year":"2015","unstructured":"Meijers, W. C., van der Velde, A. R., Pascual-Figal, D. A., & de Boer, R. A. (2015). Galectin-3 and post-myocardial infarction cardiac remodeling. European Journal of Pharmacology, 763, 115\u2013121.","journal-title":"European Journal of Pharmacology"},{"key":"9761_CR23","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nrd2660","volume":"7","author":"R Kakkar","year":"2008","unstructured":"Kakkar, R., & Lee, R. T. (2008). The IL-33\/ST2 pathway: therapeutic target and novel biomarker. Nature Reviews. Drug Discovery, 7, 827\u2013840.","journal-title":"Nature Reviews. Drug Discovery"},{"key":"9761_CR24","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1161\/CIRCHEARTFAILURE.109.873240","volume":"2","author":"K Seki","year":"2009","unstructured":"Seki, K., Sanada, S., Kudinova, A. Y., Steinhauser, M. L., Handa, V., Gannon, J., & Lee, R. T. (2009). Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling. Circulation. Heart Failure, 2, 684\u2013691.","journal-title":"Circulation. Heart Failure"},{"key":"9761_CR25","volume-title":"RELAX-AHF-2: serelaxin in acute heart failure","author":"J Teerlink","year":"2017","unstructured":"Teerlink, J., & Metra, M. (2017). RELAX-AHF-2: serelaxin in acute heart failure. Paris: Heart Failure and the 4th World Congress on Acute Heart Failure https:\/\/www.escardio.org\/The-ESC\/Press-Office\/Press-releases\/serelaxin-fails-to-meet-primary-endpoints-in-phase-3-relax-ahf-2-trial . Accessed 20 June 2017."}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12265-017-9761-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-017-9761-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-017-9761-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T02:04:34Z","timestamp":1750644274000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12265-017-9761-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,17]]},"references-count":25,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["9761"],"URL":"https:\/\/doi.org\/10.1007\/s12265-017-9761-1","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"type":"print","value":"1937-5387"},{"type":"electronic","value":"1937-5395"}],"subject":[],"published":{"date-parts":[[2017,7,17]]}}}